Form 4: Editas Medicine CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Editas Medicine CEO Gilmore O'Neill sold 16,632 shares of common stock on March 4, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 4, 2025, Gilmore O'Neill, CEO of Editas Medicine, sold 16,632 shares of common stock at a weighted average price of $1.7107 per share.
- The sale was executed under a pre-existing automatic sales instruction plan adopted on April 13, 2022.
- The transaction was necessary to meet tax withholding obligations resulting from the vesting of restricted stock units on March 3, 2025.
- Following the transaction, O'Neill directly owns 295,474 shares of Editas Medicine.
- O'Neill has also granted limited power of attorney to Gilmore O'Neill, Damien Grierson, and Amy Parison for Section 16 reporting obligations.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with equity-based compensation.
Key Dates
| Date | Description |
|---|---|
| 2022/04/13 | Date of adoption of the durable automatic sales instruction plan. |
| 2025/03/03 | Date of vesting in restricted stock units. |
| 2025/03/04 | Date of the stock sale transaction. |
| 2025/03/05 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.